Regenxbio (RGNX) EPS (Diluted) (2016 - 2025)

Regenxbio (RGNX) EPS (Diluted) (2016 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - 0.00
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 0.00
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 0.15
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 4.02
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 6.75
7 Belite Bio 61.40 Bn 61.40 Bn - 0.00
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn 5.52
9 Revolution Medicines 37.37 Bn 37.37 Bn - -2.29
10 Regenxbio 501.81 Mn 271.74 Mn 21.22 Mn 1.74

Historic Data

Download Data
DateValue
Dec 31, 2025 1.74
Sep 30, 2025 -1.27
Jun 30, 2025 -1.38
Mar 31, 2025 0.07
Dec 31, 2024 -1.35
Sep 30, 2024 -1.18
Jun 30, 2024 -1.07
Mar 31, 2024 -1.62
Dec 31, 2023 -1.44
Sep 30, 2023 -1,407.85
Jun 30, 2023 -1,655.40
Mar 31, 2023 -1,534.51
Dec 31, 2022 6.47
Sep 30, 2022 -1,745.25
Jun 30, 2022 -1,581.48
Mar 31, 2022 -1,786.58
Dec 31, 2021 6.70
Sep 30, 2021 -1.37
Jun 30, 2021 -1,355.89
Mar 31, 2021 -1.34